Biomedtracker: see the drug development process through analysts’ eyes

Biomedtracker, Meddevicetracker

Q3 2021 Outlook Report

27 Aug 2021

What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report and infographic to find out. Shape your strategy with your inside look at what’s to come.

Topic Drug Review

Datamonitor Healthcare, Biomedtracker, Scrip

2021 Post-ASCO Insights and Analysis

11 Aug 2021

The American Society of Clinical Oncology (ASCO) hosted its annual meeting from June 4-8 2021 and our team has the exclusive insights and analysis you can access today.

Topic Cancer

Biomedtracker

2020 Deal-Making Roundup

21 May 2021

Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

Topic Coronavirus

Topic Cardiovascular Coronavirus

Biomedtracker

Biopharma Partnering and Financing Trends, H1 2020 Whitepaper

By Patricia Giglio 08 Apr 2021

Get an inside view into the trends powering COVID-era deal making in the life sciences with your free copy of “Biopharma Partnering and Financing Trends, H1 2020”. Informa Pharma Intelligence takes you inside the forces shaping the industry

Topic BIO-Europe

Biomedtracker

2021 Clinical Development Success Rates

03 Mar 2021

This is both an updated study of clinical drug development success rates from our 2016 report, and an expansion into the drivers of success with the addition of machine learning modeling to analyze the predictive factors contributing to drug development.

Topic Clinical Trials Drug Development Landscape Drug Pricing

Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet...

COVID-19 Infographic

27 Nov 2020

Access the infographic below which explores the number of treatment drugs for COVID-19 currently in clinical trials or in development, events including progress updates, partnerships, regulatory and trial announcements etc, and the number of articles published on COVID-19 as of March 3, 2020. This data has been tracked and reported via Informa Pharma Intelligence’s clinical, regulatory and commercial data and analytics, and news and insight tools including Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet, Medtech Insight, and Generics Bulletin etc.

Topic Coronavirus

Datamonitor Healthcare, Biomedtracker

COVID-19 and the impact on the clinical trial space

By Dustin Phan 27 Nov 2020

The effect of COVID-19 on clinical trials, the industry response, and the return to full operations

Topic Coronavirus Clinical Trials

Biomedtracker

A Historic Decade of Deal Making

27 Nov 2020

In preparation for the webinar, download your free infographic, a snapshot view of M&A’s biggest deals and major players and what their activities indicate for the year ahead.

Topic M A

Biomedtracker

A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

By Daniel Chancellor 27 Nov 2020

Using M&A activity as a barometer for the overall health of the biopharma industry, we explore biopharma’s biggest deals of the past decade and examine what they may presage for the year to come. Dive into key insights on trends, M&A drivers, companies to watch, and more. 

Topic M A

Pharmaprojects, Biomedtracker

The Race to Find a COVID-19 Treatment - Infographic

29 Apr 2020

Access this infographic which focuses on Gilead’s drug Remdesivir which currently shows the greatest promise for the likelihood of approval as a possible treatment to effectively treat the virus. The infographic highlights the drug summary and profile, the number of patients in each trial phase, and the history of events that have moved this product through the development process.

Topic Coronavirus FDA Drug Review